Cardiatis Completes Patient Recruitment for Pivotal European Clinical Trial of its FluidSmart 3D Multilayer Stent
 |
| Cardiatis-Logo |
|
|
|
|
Cardiatis, SA announced today that it has completed recruitment of patients into its first-in-man European clinical trial of its 3D Multilayer Braided Stent for repairing aneurysms. Patient recruitment, which began in December 2006, culminates four years of extensive concept testing that demonstrated the ability of the 3D multilayer stent to repair aneurysms endovascularly without need for coils or stent grafts. Brussels, Belgium (PRWEB) August 16, 2007 -- Cardiatis, SA announced today that it has completed recruitment of patients into its first-in-man European clinical trial of its 3D Multilayer Braided Stent for repairing aneurysms. Patient recruitment, which began in December 2006, culminates four years of extensive concept testing that demonstrated the ability of the 3D multilayer stent to repair aneurysms endovascularly without need for coils or stent grafts. "The spatial three-dimensional design of the multilayer stent slows and laminates blood flow within the aneurysm minimizing chances of aneurysm rupture and allowing an organized thrombus to form" stated Patricia Gruffaz, Cardiatis Head of Research & Development. Extensive pre-clinical tests including theoretical simulation utilizing Computerized Fluid Dynamics (CFD), Lattice Boltzmann, and Molecular Modelization methods, in-vitro modeling using Particle Image Velocimetry (PIV) methods as well as a complete in-vivo testing program of different animal aneurysm models have all demonstrated the soundness and feasibility of the fluid dynamic modulation concept for endovascular aneurysm repair. "Entering this final stage of patient recruitment is an important milestone for Cardiatis and we are very grateful to the patients and their physicians involved in this trial." stated Noureddine Frid, Cardiatis President. "With the completion of patient recruitment behind us, we can now look forward to a CE filling before the end of this year." About Cardiatis Cardiatis, an innovative medical technology company located in Belgium, is focused on developing its patented FluidSmart 3D multilayer stent technology platform, a next generation technology for endovascular aneurysm repair. Additional information can be found on Cardiatis web site at http://www.cardiatis.com ###
Simillar Articles
 | | First Popliteal Aneurysm Patient Successfully Treated With Cardiatis FluidSmart 3D Multilayer... |
| Cardiatis, SA announces successful treatment of the first popliteal aneurysm patient with the Cardiatis FluidSmart 3D Multilayer Braided Stent. FluidSmart, an investigational device in the... |
|
 | | Successful Exclusion of a Renal Artery Aneurysm (RAA) with Cardiatis FluidSmart 3D Multilayer Stent |
| Cardiatis, SA announces the successful treatment of the first renal artery aneurysm (RAA) patient with the Company's FluidSmart Three Dimensional Multilayer Braided Stent. FluidSmart, an... |
|
 | | Revolutionary New Technique Uses Onyx to Fill Hard-to-Treat Aneurysms |
| CINN's Dr. Demetrius Lopes is one of the first in the country to use a new noninvasive technique to treat brain aneurysms. The technique involves a new liquid polymer material, Onyx, which is... |
|
 | | ESPN's Peter Gammons Discusses Long Road Back From Aneurysm |
| He speaks out in support of people, like himself, who have thrived under the care of professionals at the Rehabilitation Hospital of the Cape and Islands. |
|
 | | M2S, Inc. releases Preview® Treatment Planning Software, Version 2.10.0 |
| M2S Inc., an industry leader in medical image management and analysis, has released version 2.10.0 of its Preview treatment planning software. M2S's Preview 3D modeling and reconstruction... |
|
|